Background: This study aimed to investigate whether the hormone peaks of es
trogen and progesterone could influence the extent of the allergic reaction
in grass-pollen-allergic women.
Methods: Twenty-three allergic women with seasonal allergic rhinitis due to
grass pollen were included in this trial. Twelve were taking oral contrace
ptives (OC) (control group), and 11 were taking no pill (target group). The
subjects were challenged with grass pollen by nasal provocation test aroun
d day 14 of their menstrual cycle (ovulation day) and again at the end of t
he cycle (day 27). The primary criteria were the subjective nasal symptoms
rhinorrhea, nasal blockage, itching, and sneezing. A further criterion was
the objectively measured nasal mucosal swelling, assessed by active anterio
r rhinomanometry. All criteria were evaluated before and 15 min after provo
cation, and the hormone status was determined on each investigation day.
Results: Comparisons of symptoms between the groups resulted in P values of
>0.05 for all symptoms at both visits except the symptom blocked nose, whi
ch was significantly lower (P=0.03) in the patients with OC intake at visit
2, and the symptom sneezing, which showed a significantly (P=0.02) higher
increase in patients taking OC at the end of the cycle. The flow decrease r
eached a greater extent in the target group than in the controls.
Conclusions: These results indicate a correlation of the hormonal situation
and the nasal allergic reactivity. OC intake led to an intensifying of neu
rogenic symptoms near the end of pill intake, a result which could be due t
o a protective effect of the endogenous progesterone, in contrast to the or
ally administered hormones.